As the cannabis industry continues to evolve, Tilray Brands, Inc. ( NASDAQ:TLRY ) emerges as a frontrunner in the global cannabis lifestyle and consumer packaged goods market. In a recent announcement, Tilray ( NASDAQ:TLRY ) unveiled its latest product lineup and 420 celebratory activations across Canada, offering consumers an array of diverse cannabis products...
It must be 420 somewhere, since the Jazz Pharmaceuticals stock is paving its way higher and higher to ultimately reach the orange target zone. Once the blue wave (b) is completed, the stock should drop all the way below the $125.36 support line and continue the correction until the end of the green wave within the yellow trading area. Once the course has hit the...
CNBX Cannabics Pharmaceuticals has an agreement with Purisys, a leading Active Pharmaceutical Iingredient manufacturer, to use its API in Phase I/II (a) clinical studies that it is planning to launch in 2022.
So this year will be quite bullish for CNBX
Cannabics Pharmaceuticals is a U.S. public company and a global leader in the development of cancer related...
Wall Street has Sundial pegged to bring in almost $540 million in sales in 2022, up from an estimated $50.5 million this year.
They are also buying Alcanna in a stock deal.
The board of directors of Alcanna unanimously recommends Alcanna Shareholders vote “FOR” the Arrangement Resolution.
The Special Meeting of Alcanna Shareholders is postponed to January 7,...
As many of you already know, I've been bullish on HITI for quite some time, waiting for the right entry. This is one of my favorite cannabis stocks, and I'm bullish the cannabis sector overall. This may not be a quick play; I'm expecting to hold my cannabis stocks for quite some time.
On the daily chart, HITI made some lower lows, while the RSI made higher...
It’s falling and falling and will continue to fall for a little longer. This should go on until a little under $9.73. There, the correction should finally end and new increases should follow.
Be patient!
With international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group’s portfolio includes PEACE...
The downtrend is still not over for the Tilray stock. It still has to move below $12.56. There, at the latest, the course needs to turn around and push to reach $31.34.
Stay trading!
Yes, WeedMD has been relatively weak over the last months, but we are within that yellow target box and, accordingly, are waiting for the breakout on the long side. The price needs to reach regions around C$0.59 in the first place, before moving on to a corrective movement. After that, we are set to push for massive increases.
Stay trading!
Nice gap up candlestick and rising volume... is this an initiation gap up or a short term short squeeze/ bear rally? Awaiting to see how it behaves in the next sessions around the gap, in case it half closes it and then moves upwards i am going to start my initial position and build gradually from there.
Recently, Aphria went all the way through our blue trading zone and we believe that the bearish movement should be over now. From here, we expect the stock’s price to increase again and crush through the mark at CAD28.78. All in all, we expect prices of above CAD37 to become reality in the near future. With a probability of only 30%, there is a chance that the...
MJ Analytics, an Akerna product built on Domo's modern BI platform, generates six figure sales increase
Within less than 90 days of launching MJ Analytics, the platform has generated a six figure increase in sales and helped clients reduce manual reporting workflows by 90% through the use of scheduled reports. With a 95% positive product feedback based on recent...
